983525

BioReliance Corporation — FEI 1122041

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 11, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rockville, MD (United States)